-+ 0.00%
-+ 0.00%
-+ 0.00%
The Zhitong Finance App learned that LLY.US (LLY.US) has agreed to acquire the privately held Calytrix Bio Inc., with a transaction value of up to 1.5 billion US dollars. This is Lilly's latest move to continue to acquire and lay out the cancer and autoimmune disease racetrack.
Share
Listen to the news
The Zhitong Finance App learned that LLY.US (LLY.US) has agreed to acquire the privately held Calytrix Bio Inc., with a transaction value of up to 1.5 billion US dollars. This is Lilly's latest move to continue to acquire and lay out the cancer and autoimmune disease racetrack.
Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.
What's Trending